ArticleNeuro-oncology2015

Interpretation of meta-analysis evaluating progression-free survival as a surrogate endpoint for overall survival in glioblastoma.

Kelong Han et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.